SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-17-000073
Filing Date
2017-05-08
Accepted
2017-05-08 16:16:34
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2017q110q.htm 10-Q 675124
2 EXHIBIT 10.1 exh101consultingagreementks.htm EX-10.1 19713
3 EXHIBIT 31.1 exh3112017q1.htm EX-31.1 13385
4 EXHIBIT 31.2 exh3122017q1.htm EX-31.2 13521
5 EXHIBIT 32.1 exh322017q1.htm EX-32.1 11245
  Complete submission text file 0001358403-17-000073.txt   3907020

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT blcm-20170331.xml EX-101.INS 737081
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20170331.xsd EX-101.SCH 32297
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20170331_cal.xml EX-101.CAL 57737
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20170331_def.xml EX-101.DEF 132642
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20170331_lab.xml EX-101.LAB 421170
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20170331_pre.xml EX-101.PRE 242531
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 17822427
SIC: 2834 Pharmaceutical Preparations